|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
COX-2 and NF-KB Overexpression is Common in Pancreatic Cancer But Does Not Predict for COX-2 Inhibitors Activity in Combination with Gemcitabine and Oxaliplatin October 1, 2007 Am J Clin Oncol. 2007 Oct;30(5):526-30.
PMID: 17921715 |
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |